Abad E, Lyakhovich A (2022) Movement of mitochondria with mutant DNA through extracellular vesicles helps cancer cells acquire chemoresistance. Chem Med Chem 17(4):e202100642

Article  CAS  PubMed  Google Scholar 

Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. https://doi.org/10.1186/s12964-020-0530-4

Article  PubMed  PubMed Central  Google Scholar 

Berger M, Neth O, Ilmer M, Garnier A, Salinas-Martín MV, de Agustín Asencio JC, von Schweinitz D, Kappler R, Muñoz M (2014) Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol 60(5):985–994

Article  CAS  PubMed  Google Scholar 

Bilousova T, Simmons BJ, Knapp RR, Elias CJ, Campagna J, Melnik M, Chandra S, Focht S, Zhu C, Vadivel K (2020) Dual neutral sphingomyelinase-2/acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease. ACS Chem Biol 15(6):1671–1684

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butt SS, Badshah Y, Shabbir M, Rafiq M (2020) Molecular docking using chimera and autodock vina software for nonbioinformaticians. JMIR Bioinform Biotechnol 1(1):e14232

Article  Google Scholar 

Cetin R, Quandt E, Kaulich M (2021) Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance. Cells 10(2):260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, Southall N, Hu X, Lal M, Mondal D (2018) High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer. Sci Rep 18(1):8161

Article  Google Scholar 

Dong LF, Rohlena J, Zobalova R, Nahacka Z, Rodriguez AM, Berridge MV, Neuzil J (2023) Mitochondria on the move: Horizontal mitochondrial transfer in disease and health. J Cell Biol. https://doi.org/10.1083/jcb.202211044

Article  PubMed  PubMed Central  Google Scholar 

Elsherbini A, Bieberich E (2018) Ceramide and exosomes: a novel target in cancer biology and therapy. Adv Cancer Res 140:121–154

Article  CAS  PubMed  PubMed Central  Google Scholar 

Figuera-Losada M, Stathis M, Dorskind JM, Thomas AG, Bandaru VVR, Yoo S-W, Westwood NJ, Rogers GW, McArthur JC, Haughey NJ (2015) Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties. PLoS ONE 10(5):e0124481

Article  PubMed  PubMed Central  Google Scholar 

Hekmatirad S, Moloudizargari M, Moghadamnia AA, Kazemi S, Mohammadnia-Afrouzi M, Baeeri M, Moradkhani F, Asghari MH (2021) Inhibition of exosome release sensitizes U937 cells to PEGylated liposomal doxorubicin. Front Immunol 12:692654

Article  CAS  PubMed  PubMed Central  Google Scholar 

Houshyari M, Taghizadeh-Hesary F (2022) Is mitochondrial metabolism a new predictive biomarker for antiprogrammed cell death Protein-1 immunotherapy? JCO Oncol Pract:OP 22:00733

Google Scholar 

Im E-J, Lee C-H, Moon P-G, Rangaswamy GG, Lee B, Lee JM, Lee J-C, Jee J-G, Bae J-S, Kwon T-K (2019) Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat Commun 10(1):1387

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javid H, Afshari AR, Zahedi Avval F, Asadi J, Hashemy SI (2021) Aprepitant promotes caspase-dependent apoptotic cell death and G2/M arrest through PI3K/Akt/NF-κB axis in cancer stem-like esophageal squamous cell carcinoma spheres. BioMed Res Int 2021:1–12

Article  Google Scholar 

Jin G, Wong ST (2014) Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 19(5):637–644

Article  PubMed  Google Scholar 

Khan FM, Saleh E, Alawadhi H, Harati R, Zimmermann W-H, El-Awady R (2018) Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin. Cancer Biol Ther 19(1):25–33

Article  CAS  PubMed  Google Scholar 

Koch R, Aung T, Vogel D, Chapuy B, Wenzel D, Becker S, Sinzig U, Venkataramani V, von Mach T, Jacob R (2016) Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantroneinhibition of exosomal drug export by indomethacin. Clin Cancer Res 22(2):395–404

Article  CAS  PubMed  Google Scholar 

Kosgodage US, Trindade RP, Thompson PR, Inal JM, Lange S (2017) Chloramidine/bisindolylmaleimide-I-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy. Int J Mol Sci 18(5):1007

Article  PubMed  PubMed Central  Google Scholar 

Mahmoud R, Ordóñez-Morán P, Allegrucci C (2022) Challenges for triple negative breast cancer treatment: defeating heterogeneity and cancer stemness. Cancers 14(17):4280

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moloudizargari M, Asghari MH, Abdollahi M (2018) Modifying exosome release in cancer therapy: how can it help? Pharmacol Res 134:246–256

Article  CAS  PubMed  Google Scholar 

Moloudizargari M, Abdollahi M, Asghari MH, Zimta AA, Neagoe IB, Nabavi SM (2019a) The emerging role of exosomes in multiple myeloma. Blood Rev 38:100595

Article  CAS  PubMed  Google Scholar 

Moloudizargari M, Asghari MH, Mortaz E (2019b) Inhibiting exosomal MIC-A and MIC-B shedding of cancer cells to overcome immune escape: new insight of approved drugs. DARU J Pharm Sci 27(2):879–884

Article  CAS  Google Scholar 

Moloudizargari M, Hekmatirad S, Mofarahe ZS, Asghari MH (2021) Exosomal microRNA panels as biomarkers for hematological malignancies. Curr Probl Cancer 45(5):100726

Article  PubMed  Google Scholar 

Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, Saland E, Castellano R, Pouyet L, Collette Y, Vey N, Chabannon C, Recher C, Sarry JE, Alcor D, Peyron JF, Griessinger E (2016) Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood 128(2):253–264. https://doi.org/10.1182/blood-2015-07-655860

Article  CAS  PubMed  Google Scholar 

Munoz M, Gonzalez-Ortega A, Salinas-Martín MV, Carranza A, Garcia-Recio S, Almendro V, Covenas R (2014) The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer. Int J Oncol 45(4):1658–1672

Article  CAS  PubMed  Google Scholar 

Nakamura K, Sawada K, Kinose Y, Yoshimura A, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Morishige K-i, Kurachi H (2017) Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells exosomes promote ovarian cancer cell invasion. Mol Cancer Res 15(1):78–92

Article  CAS  PubMed  Google Scholar 

Ni Z, Zhou S, Li S, Kuang L, Chen H, Luo X, Ouyang J, He M, Du X, Chen L (2020) Exosomes: roles and therapeutic potential in osteoarthritis. Bone Res. https://doi.org/10.1038/s41413-020-0100-9

Article  PubMed  PubMed Central  Google Scholar 

Obaidullah AJ, Alanazi MM, Alsaif NA, Alanazi AS, Albassam H, Az A, Alwassil OI, Alqahtani AM, Tareq AM (2022) Network pharmacology-and molecular docking-based identification of potential phytocompounds from Argyreia capitiformis in the treatment of inflammation. Evid-Based Complement Altern Med 2022:1–22

Article  Google Scholar 

Olver I, Shelukar S, Thompson KC (2007) Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant. Int J Nanomed 2(1):13–18

Article  CAS  Google Scholar 

Richards KE, Zeleniak AE, Fishel ML, Wu J, Littlepage LE, Hill R (2017) Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene 36(13):1770–1778

Article  CAS  PubMed  Google Scholar 

Rojas C, Barnaeva E, Thomas AG, Hu X, Southall N, Marugan J, Chaudhuri AD, Yoo S-W, Hin N, Stepanek O (2018) DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation. Sci Rep 8(1):17715

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rojas C, Sala M, Thomas AG, Datta Chaudhuri A, Yoo SW, Li Z, Dash RP, Rais R, Haughey NJ, Nencka R (2019) A novel and potent brain penetrant inhibitor of extracellular vesicle release. Br J Pharmacol 176(19):3857–3870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saputra EC, Huang L, Chen Y, Tucker-Kellogg L (2018) Combination therapy and the evolution of resistance: the theoretical merits of synergism and antagonism in cancer. Cancer Res 78(9):2419–2431

Article  CAS  PubMed  Google Scholar 

Son B, Lee S, Youn H, Kim E, Kim W, Youn B (2017) The role of tumor microenvironment in therapeutic resistance. Oncotarget 8(3):3933

Article  PubMed  Google Scholar 

Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova I-I (2019) Therapy resistance mediated by exosomes. Mol Cancer 18(1):1–11

Article  Google Scholar 

Taghizadeh-Hesary F, Houshyari M, Farhadi M (2023) Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-023-04592-7

Article  PubMed  Google Scholar